| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |